Jeffrey Smith
Faculty Member
Last active: 3/14/2018

  1. Genetic variants and prostate cancer risk: candidate replication and exploration of viral restriction genes. Breyer JP, McReynolds KM, Yaspan BL, Bradley KM, Dupont WD, Smith JR (2009) Cancer Epidemiol Biomarkers Prev 18(7): 2137-44
    › Primary publication · 19567509 (PubMed) · PMC2813685 (PubMed Central)
  2. Androgen regulated genes in human prostate xenografts in mice: relation to BPH and prostate cancer. Love HD, Booton SE, Boone BE, Breyer JP, Koyama T, Revelo MP, Shappell SB, Smith JR, Hayward SW (2009) PLoS One 4(12): e8384
    › Primary publication · 20027305 (PubMed) · PMC2793011 (PubMed Central)
  3. Haplotype analyses of CYP19A1 gene variants and breast cancer risk: results from the Shanghai Breast Cancer Study. Cai Q, Kataoka N, Li C, Wen W, Smith JR, Gao YT, Shu XO, Zheng W (2008) Cancer Epidemiol Biomarkers Prev 17(1): 27-32
    › Primary publication · 18199708 (PubMed) · PMC2633134 (PubMed Central)
  4. Genetic differences in human circadian clock genes among worldwide populations. Ciarleglio CM, Ryckman KK, Servick SV, Hida A, Robbins S, Wells N, Hicks J, Larson SA, Wiedermann JP, Carver K, Hamilton N, Kidd KK, Kidd JR, Smith JR, Friedlaender J, McMahon DG, Williams SM, Summar ML, Johnson CH (2008) J Biol Rhythms 23(4): 330-40
    › Primary publication · 18663240 (PubMed) · PMC2579796 (PubMed Central)
  5. Association of mitochondrial DNA displacement loop (CA)n dinucleotide repeat polymorphism with breast cancer risk and survival among Chinese women. Ye C, Gao YT, Wen W, Breyer JP, Shu XO, Smith JR, Zheng W, Cai Q (2008) Cancer Epidemiol Biomarkers Prev 17(8): 2117-22
    › Primary publication · 18708405 (PubMed) · PMC2643086 (PubMed Central)
  6. A haplotype at chromosome Xq27.2 confers susceptibility to prostate cancer. Yaspan BL, McReynolds KM, Elmore JB, Breyer JP, Bradley KM, Smith JR (2008) Hum Genet 123(4): 379-86
    › Primary publication · 18350320 (PubMed) · PMC2811403 (PubMed Central)
  7. Haplotype analysis of CYP11A1 identifies promoter variants associated with breast cancer risk. Yaspan BL, Breyer JP, Cai Q, Dai Q, Elmore JB, Amundson I, Bradley KM, Shu XO, Gao YT, Dupont WD, Zheng W, Smith JR (2007) Cancer Res 67(12): 5673-82
    › Primary publication · 17575134 (PubMed) · PMC2805128 (PubMed Central)
  8. A major zebrafish polymorphism resource for genetic mapping. Bradley KM, Elmore JB, Breyer JP, Yaspan BL, Jessen JR, Knapik EW, Smith JR (2007) Genome Biol 8(4): R55
    › Primary publication · 17428331 (PubMed) · PMC1896001 (PubMed Central)
  9. Polymorphisms in ER-alpha gene interact with estrogen receptor status in breast cancer survival. Boyapati SM, Shu XO, Ruan ZX, Cai Q, Smith JR, Wen W, Gao YT, Zheng W (2005) Clin Cancer Res 11(3): 1093-8
    › Primary publication · 15709176 (PubMed)
  10. Insulin-like growth factor-I gene polymorphism and breast cancer risk in Chinese women. Wen W, Gao YT, Shu XO, Yu H, Cai Q, Smith JR, Zheng W (2005) Int J Cancer 113(2): 307-11
    › Primary publication · 15386404 (PubMed)